Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 338 items for :

  • "Thyroid cancer" x
Clear All
Constance Xhaard U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Constance Xhaard in
Google Scholar
PubMed Close
,
Juan J. Lence-Anta National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Juan J. Lence-Anta in
Google Scholar
PubMed Close
,
Yan Ren U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Yan Ren in
Google Scholar
PubMed Close
,
Françoise Borson-Chazot Groupement Hospitalier Lyon-Est, Hospices Civils de Lyon, Fédération d'Endocrinologie, Bron
Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon

Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed Close
,
Geneviève Sassolas Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon

Search for other papers by Geneviève Sassolas in
Google Scholar
PubMed Close
,
Claire Schvartz Thyroid Cancer Registry of Champagne-Ardennes, Institut Jean Godinot, Reims

Search for other papers by Claire Schvartz in
Google Scholar
PubMed Close
,
Marc Colonna Cancer Registry of Isère, Meylan

Search for other papers by Marc Colonna in
Google Scholar
PubMed Close
,
Brigitte Lacour Institut Gustave Roussy, Villejuif, France
French National Registry of Childhood Solid Tumours, CHU, Nancy

Search for other papers by Brigitte Lacour in
Google Scholar
PubMed Close
,
Arlette Danzon Cancer Registry of Doubs, EA 3181, Université de Franche-Comté, Besançon

Search for other papers by Arlette Danzon in
Google Scholar
PubMed Close
,
Michel Velten Cancer Registry of Bas-Rhin, EA 3430, Faculty of Medicine, University of Strasbourg, Strasbourg

Search for other papers by Michel Velten in
Google Scholar
PubMed Close
,
Enora Clero U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Enora Clero in
Google Scholar
PubMed Close
,
Stéphane Maillard U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Stéphane Maillard in
Google Scholar
PubMed Close
,
Emilie Marrer Cancer Registry of Haut-Rhin, Mulhouse Hospital, Mulhouse

Search for other papers by Emilie Marrer in
Google Scholar
PubMed Close
,
Laurent Bailly Public Health Department, University Hospital Nice, Nice

Search for other papers by Laurent Bailly in
Google Scholar
PubMed Close
,
Eugènia Mariné Barjoan Public Health Department, University Hospital Nice, Nice

Search for other papers by Eugènia Mariné Barjoan in
Google Scholar
PubMed Close
,
Martin Schlumberger Institut Gustave Roussy, Villejuif, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed Close
,
Jacques Orgiazzi Department of Endocrinology, Hospices Civils de Lyon, Lyon, France

Search for other papers by Jacques Orgiazzi in
Google Scholar
PubMed Close
,
Elisabeth Adjadj U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Elisabeth Adjadj in
Google Scholar
PubMed Close
,
Celia M. Pereda National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Celia M. Pereda in
Google Scholar
PubMed Close
,
Silvia Turcios National Institute of Endocrinology, Cuba

Search for other papers by Silvia Turcios in
Google Scholar
PubMed Close
,
Milagros Velasco National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Milagros Velasco in
Google Scholar
PubMed Close
,
Mae Chappe National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Mae Chappe in
Google Scholar
PubMed Close
,
Idalmis Infante National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Idalmis Infante in
Google Scholar
PubMed Close
,
Marlene Bustillo National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Marlene Bustillo in
Google Scholar
PubMed Close
,
Anabel García National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Anabel García in
Google Scholar
PubMed Close
,
Sirced Salazar National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Sirced Salazar in
Google Scholar
PubMed Close
,
Regla Rodriguez Cuban Public Health Ministry, Havana, Cuba

Search for other papers by Regla Rodriguez in
Google Scholar
PubMed Close
,
Mohamed Amine Benadjaoud U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Mohamed Amine Benadjaoud in
Google Scholar
PubMed Close
,
Rosa M. Ortiz National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Rosa M. Ortiz in
Google Scholar
PubMed Close
,
Carole Rubino U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Carole Rubino in
Google Scholar
PubMed Close
, and
Florent de Vathaire U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Florent de Vathaire in
Google Scholar
PubMed Close

Introduction Over the last few decades, the differentiated thyroid cancer (DTC) incidence has grown rapidly in many countries [ 1 ]. The study of DTC risk factors is therefore of great importance to understand this observed increase in

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000445887
Volume/Issue:
Volume 5: Issue 2
Free access
Valentina M. Drozd The International Fund “Help for patients with radiation-induced thyroid cancer ‘Arnica’”, Minsk, Belarus
Project Chernobyl, Brooklyn, New York, USA

Search for other papers by Valentina M. Drozd in
Google Scholar
PubMed Close
,
Igor Branovan Project Chernobyl, Brooklyn, New York, USA

Search for other papers by Igor Branovan in
Google Scholar
PubMed Close
,
Nikolay Shiglik Project Chernobyl, Brooklyn, New York, USA

Search for other papers by Nikolay Shiglik in
Google Scholar
PubMed Close
,
Johannes Biko Clinic and Polyclinic of Nuclear Medicine, University of Würzburg, Würzburg, Germany

Search for other papers by Johannes Biko in
Google Scholar
PubMed Close
, and
Christoph Reiners The International Fund “Help for patients with radiation-induced thyroid cancer ‘Arnica’”, Minsk, Belarus
Clinic and Polyclinic of Nuclear Medicine, University of Würzburg, Würzburg, Germany

Search for other papers by Christoph Reiners in
Google Scholar
PubMed Close

Introduction During the last 30 years, the incidence of differentiated thyroid cancer (DTC) has steadily increased worldwide, most markedly in France, Italy, the Republic of Korea, Australia, and the USA [ 1 - 8 ]. In the USA, DTC incidence is

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000485971
Volume/Issue:
Volume 7: Issue 2
Open access
C. Mari Aparici Nuclear Medicine, Radiology Department, University of California San Francisco, UCSF
Nuclear Medicine, Radiology Department, San Francisco VA Medical Center, San Francisco, Calif., USA

Search for other papers by C. Mari Aparici in
Google Scholar
PubMed Close
and
T. Liu Nuclear Medicine, Radiology Department, University of California San Francisco, UCSF

Search for other papers by T. Liu in
Google Scholar
PubMed Close

What Is Known about This Topic • Very little is known about lymphatic spread of thyroid cancer outside the regional lymphatic nodal stations. What This Case Report Adds • It shows for the first time metastatic disease from thyroid

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000355910
Volume/Issue:
Volume 3: Issue 1
Free access
Francesca Carlomagno Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano, Università degli Studi di Napoli Federico II, Napoli, Italia

Search for other papers by Francesca Carlomagno in
Google Scholar
PubMed Close

-derived calcitonin-producing thyroid parafollicular C cells and represents 5–10% of all thyroid cancers. Although most MTCs are sporadic and affect adult patients, around 25% of cases are familial and occur in the frame of inherited cancer syndromes called multiple

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000336975
Volume/Issue:
Volume 1: Issue 1
Free access
Yoon Young Cho Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Seoul, Republic of Korea

Search for other papers by Yoon Young Cho in
Google Scholar
PubMed Close
,
Hye Won Jang Department of Medical Education, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Search for other papers by Hye Won Jang in
Google Scholar
PubMed Close
,
Ji Young Joung Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Seoul, Republic of Korea

Search for other papers by Ji Young Joung in
Google Scholar
PubMed Close
,
Sun-Mi Park Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Seoul, Republic of Korea

Search for other papers by Sun-Mi Park in
Google Scholar
PubMed Close
,
Dae Joon Jeong Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Seoul, Republic of Korea

Search for other papers by Dae Joon Jeong in
Google Scholar
PubMed Close
,
Sun Wook Kim Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Seoul, Republic of Korea

Search for other papers by Sun Wook Kim in
Google Scholar
PubMed Close
, and
Jae Hoon Chung Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Seoul, Republic of Korea

Search for other papers by Jae Hoon Chung in
Google Scholar
PubMed Close

Introduction Childhood thyroid cancer is a rare malignancy, but its incidence has been gradually increasing according to several epidemiologic studies [ 1 , 2 ]. An increase in the incidence of childhood thyroid cancer (aged 0-14 years) was

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000442047
Volume/Issue:
Volume 4: Issue 4
Free access
Friederike Schütz Martin Luther University Halle-Wittenberg, Institute for Medical Epidemiology, Biostatistics and Informatics, Halle (Saale), Germany

Search for other papers by Friederike Schütz in
Google Scholar
PubMed Close
,
Christine Lautenschläger Martin Luther University Halle-Wittenberg, Institute for Medical Epidemiology, Biostatistics and Informatics, Halle (Saale), Germany

Search for other papers by Christine Lautenschläger in
Google Scholar
PubMed Close
,
Kerstin Lorenz Department of General, Visceral and Vascular Surgery, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Search for other papers by Kerstin Lorenz in
Google Scholar
PubMed Close
, and
Johannes Haerting Martin Luther University Halle-Wittenberg, Institute for Medical Epidemiology, Biostatistics and Informatics, Halle (Saale), Germany

Search for other papers by Johannes Haerting in
Google Scholar
PubMed Close

Introduction Thyroid cancer is the most common endocrine cancer, responsible for approximately 1% of all malignant diseases [ 1 ]. Since the end of the 1990s, the incidence of thyroid cancers in women has increased to nearly double in Germany

Article Type:
Meta Analysis
DOI:
https://doi.org/10.1159/000481707
Volume/Issue:
Volume 7: Issue 1
Free access
Mohammad-Reza Mahmoudian-sani Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Department of Genetics and Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Search for other papers by Mohammad-Reza Mahmoudian-sani in
Google Scholar
PubMed Close
,
Ameneh Mehri-Ghahfarrokhi Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

Search for other papers by Ameneh Mehri-Ghahfarrokhi in
Google Scholar
PubMed Close
,
Majid Asadi-Samani Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran

Search for other papers by Majid Asadi-Samani in
Google Scholar
PubMed Close
, and
Gholam-Reza Mobini Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

Search for other papers by Gholam-Reza Mobini in
Google Scholar
PubMed Close

Introduction Thyroid cancer is the most common endocrine malignancy and accounts for about 1% of cancers [ 1 , 2 ]. According to research findings, the degree of malignancy of this cancer in women is 3 times more than that in men, which is

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000468520
Volume/Issue:
Volume 6: Issue 4
Free access
Matthieu Bosset Fédération d’Endocrinologie, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France

Search for other papers by Matthieu Bosset in
Google Scholar
PubMed Close
,
Maxime Bonjour Service de Biostatistique, Hospices Civils de Lyon, Lyon, France

Search for other papers by Maxime Bonjour in
Google Scholar
PubMed Close
,
Solène Castellnou Fédération d’Endocrinologie, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France

Search for other papers by Solène Castellnou in
Google Scholar
PubMed Close
,
Zakia Hafdi-Nejjari Registre des Cancers Thyroïdiens du Département du Rhône, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France

Search for other papers by Zakia Hafdi-Nejjari in
Google Scholar
PubMed Close
,
Claire Bournaud-Salinas Centre de Médecine Nucléaire, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France

Search for other papers by Claire Bournaud-Salinas in
Google Scholar
PubMed Close
,
Myriam Decaussin-Petrucci Service d’Anatomie-Pathologique, Hospices Civils de Lyon, Groupement Hospitalier Lyon-Sud, Pierre Bénite, France

Search for other papers by Myriam Decaussin-Petrucci in
Google Scholar
PubMed Close
,
Jean Christophe Lifante Service de Chirurgie Endocrinienne, Hospices Civils de Lyon, Groupement Hospitalier Lyon-Sud, Pierre Bénite, France
Laboratoire Health Services and Performance Research (EA 7425 HESPER), Université Claude Bernard Lyon 1, Villeurbanne, France

Search for other papers by Jean Christophe Lifante in
Google Scholar
PubMed Close
,
Agnès Perrin Fédération d’Endocrinologie, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France

Search for other papers by Agnès Perrin in
Google Scholar
PubMed Close
,
Jean-Louis Peix Service de Chirurgie Endocrinienne, Hospices Civils de Lyon, Groupement Hospitalier Lyon-Sud, Pierre Bénite, France

Search for other papers by Jean-Louis Peix in
Google Scholar
PubMed Close
,
Philippe Moulin Fédération d’Endocrinologie, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France
CarMeN Laboratory, Université Claude-Bernard Lyon 1, Inserm U1060, INRA U1397, INSA Lyon, IMBL, Villeurbanne, France

Search for other papers by Philippe Moulin in
Google Scholar
PubMed Close
,
Geneviève Sassolas Registre des Cancers Thyroïdiens du Département du Rhône, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France

Search for other papers by Geneviève Sassolas in
Google Scholar
PubMed Close
,
Michel Pugeat Fédération d’Endocrinologie, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France

Search for other papers by Michel Pugeat in
Google Scholar
PubMed Close
, and
Françoise Borson-Chazot Fédération d’Endocrinologie, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France
Registre des Cancers Thyroïdiens du Département du Rhône, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France
Laboratoire Health Services and Performance Research (EA 7425 HESPER), Université Claude Bernard Lyon 1, Villeurbanne, France

Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed Close

Introduction Thyroid cancer is the most common endocrine malignancy, and its incidence globally has increased over the last 30 years [ 1 , 2 ]. Papillary thyroid cancer (PTC) represents more than 90% of all thyroid cancer cases and is the

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000510620
Volume/Issue:
Volume 10: Issue 6
Free access
Brigitte Decallonne Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium

Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed Close
,
Annick Van den Bruel Department of Endocrinology, General Hospital St Jan, Bruges, Belgium

Search for other papers by Annick Van den Bruel in
Google Scholar
PubMed Close
,
Gilles Macq Department of Research, Belgian Cancer Registry, Brussels, Belgium

Search for other papers by Gilles Macq in
Google Scholar
PubMed Close
,
Nathalie Elaut Department of Research, Belgian Cancer Registry, Brussels, Belgium

Search for other papers by Nathalie Elaut in
Google Scholar
PubMed Close
, and
Harlinde De Schutter Department of Research, Belgian Cancer Registry, Brussels, Belgium

Search for other papers by Harlinde De Schutter in
Google Scholar
PubMed Close

Introduction In Belgium, higher thyroid cancer incidence – most pronounced for microcancers (T1a) – is present in the Southern region, Wallonia, compared to the Northern region, Flanders. In a pioneer national population

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000504046
Volume/Issue:
Volume 9: Issue 1
Free access
Ayanthi Wijewardene Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Ayanthi Wijewardene in
Google Scholar
PubMed Close
,
Matti Gild Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Matti Gild in
Google Scholar
PubMed Close
,
Carolina Nylén Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Carolina Nylén in
Google Scholar
PubMed Close
,
Geoffrey Schembri Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Geoffrey Schembri in
Google Scholar
PubMed Close
,
Paul Roach Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Paul Roach in
Google Scholar
PubMed Close
,
Jeremy Hoang Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Jeremy Hoang in
Google Scholar
PubMed Close
,
Ahmad Aniss Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Ahmad Aniss in
Google Scholar
PubMed Close
,
Anthony Glover Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Anthony Glover in
Google Scholar
PubMed Close
,
Mark Sywak Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Mark Sywak in
Google Scholar
PubMed Close
,
Stan Sidhu Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Stan Sidhu in
Google Scholar
PubMed Close
,
Diana Learoyd Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Diana Learoyd in
Google Scholar
PubMed Close
,
Bruce Robinson Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Bruce Robinson in
Google Scholar
PubMed Close
,
Lyndal Tacon Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Lyndal Tacon in
Google Scholar
PubMed Close
, and
Roderick Clifton-Bligh Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed Close

Introduction The incidence of thyroid cancer is increasing worldwide [ 1 ]. In Australia, thyroid cancer is increasing more than any other malignancy, with incidence rising from 2.7 to 13 per 100,000 persons between 1982 and 2019 [ 2 , 3

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000516358
Volume/Issue:
Volume 10: Issue 5
Free access